With FDA input, compassionate use programs appear to work well: study

(Reuters Health) - When terminally ill Americans receive experimental medicines through so-called "compassionate use" programs, they typically only get these drugs after extensive tests for safety and effectiveness, a U.S. study suggests.

from Reuters: Health News https://ift.tt/2JNG5Ep